Whitepaper: Making MS-based glycan analysis easier
Recent technological advances have made it easier to cope with the complexity of mass spectrometry (MS) based glycan analysis.
Glycosylation occurs in expression systems for producing biological drugs, creating a complex spectrum of N- and O-linked glycans that vary significantly with regards to in vivo stability, solubility, activity, safety, and efficacy. This makes glycoprotein analysis a challenging task that is performed at several levels: intact protein, subunit, peptide, and glycan. This white paper presents recent advances in MS-based methods to reduce the task’s complexity at all four levels.
Related content from this organisation
- Microbial air sampler market to value $545mn by 2028
- Has the threat of waiving COVID-19 vaccine intellectual property rights had its desired effect?
- 2021 a pivotal year for personalised neoantigens, says GlobalData
- Strengthening the pharma industry’s cyber security defence
- Collaboration to develop neurostimulator for inflammatory disease treatment